For citations:
Savenkova N.D., Ivanov D.O., Lubimova O.V., Barsukova V.N., Pankov E.A., Fedotova E.P., Dmitrieva E.M. The use of the drug Elizaria – a biosimilar of the original eculizumab in atypical hemolytic-uremic syndrome due to mutation of the С3 gene in children: clinical observation and literature review. Nephrology (Saint-Petersburg). 2023;27(1):92-101. (In Russ.) https://doi.org/10.36485/1561-6274-2023-27-1-92-101
Email this article 